Article Details

SpliceBio: $135 Million Series B Raised For Expanding Pipeline Of Genetic Medicines

Retrieved on: 2025-06-19 04:18:25

Tags for this article:

Click the tags to see associated articles and topics

SpliceBio: $135 Million Series B Raised For Expanding Pipeline Of Genetic Medicines. View article details on hiswai:

Excerpt

... as all existing investors: New Enterprise Associates, UCB Ventures, Ysios Capital, Gilde Healthcare, Novartis Venture Fund, and Asabys Partners.

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo